Evolus (EOLS) Accumulated Expenses (2017 - 2026)
Evolus (EOLS) reported Accumulated Expenses of $31.9 million for Q1 2026, up 19.76% on a YoY basis from $26.6 million in Q1 2025, and down 10.43% quarter-over-quarter from $35.6 million in Q4 2025.
Evolus (EOLS) Accumulated Expenses (2017 - 2026) Analysis & Trends
Evolus has reported Accumulated Expenses for 10 years, with the latest figure at $31.9 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 19.76% year-over-year to $31.9 million; the trailing twelve-month figure through Mar 2026 stood at $31.9 million (up 19.76% YoY), and the FY2025 full-year result was $35.6 million, down 12.75% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $31.9 million, down from $35.6 million in the prior quarter.
- The five-year high for Accumulated Expenses was $40.8 million in Q4 2024, with the low at $21.1 million in Q1 2022.
- Historically, Accumulated Expenses has averaged $29.3 million across 5 years, with a median of $28.5 million in 2022.
- The largest YoY upside for Accumulated Expenses was 68.21% in 2022 against a maximum downside of 17.33% in 2022.
- Evolus' Accumulated Expenses stood at $24.8 million in 2022, then surged by 36.38% to $33.8 million in 2023, then grew by 20.64% to $40.8 million in 2024, then decreased by 12.75% to $35.6 million in 2025, then slipped by 10.43% to $31.9 million in 2026.
- The last three Accumulated Expenses figures came in at $31.9 million (Q1 2026), $35.6 million (Q4 2025), and $30.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.88 Mn |
| Dec 31, 2025 | 35.59 Mn |
| Sep 30, 2025 | 30.46 Mn |
| Jun 30, 2025 | 27.95 Mn |
| Mar 31, 2025 | 26.62 Mn |
| Dec 31, 2024 | 40.79 Mn |
| Sep 30, 2024 | 34.95 Mn |
| Jun 30, 2024 | 32.79 Mn |
| Mar 31, 2024 | 25.05 Mn |
| Dec 31, 2023 | 33.81 Mn |
| Sep 30, 2023 | 26.71 Mn |
| Jun 30, 2023 | 24.18 Mn |
| Mar 31, 2023 | 22.11 Mn |
| Dec 31, 2022 | 24.79 Mn |
| Sep 30, 2022 | 29.88 Mn |
| Jun 30, 2022 | 28.54 Mn |
| Mar 31, 2022 | 21.14 Mn |
| Dec 31, 2021 | 29.99 Mn |
| Sep 30, 2021 | 23.44 Mn |
| Jun 30, 2021 | 24.36 Mn |